Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights

1. SCD is the most common inherited blood disorder. In SCD, mutated hemoglobin S will polymerize in the deoxygenated state, which leads to sickle cell formation that causes a cascade of hemolysis, ...

Authors

Institutions

Publication Details

Journal
Expert Opinion on Investigational Drugs
Published
2026-06-17
DOI
https://doi.org/10.1080/13543784.2026.2689654
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights

Galia Pollock, Susanna Curtis, Jordan Bellis, Lydia Monk et al.
Expert Opinion on Investigational Drugs
Hemoglobinopathies and Related Disorders
article

Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights

Galia Pollock, Susanna Curtis, Jordan Bellis, Lydia Monk, Charleen Jacobs-McFarlane
article en

Abstract

1. SCD is the most common inherited blood disorder. In SCD, mutated hemoglobin S will polymerize in the deoxygenated state, which leads to sickle cell formation that causes a cascade of hemolysis, ...

Expert Opinion on Investigational Drugs
Icahn School of Medicine at Mount Sinai (US)
Good health and well-being
Openalex Percentile: Top 6%
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.